<![CDATA[Does Patient Selection Inflate CAR T Outcomes in Multiple Myeloma? ]]>

ConferenceCAR T-cell therapyNeutral

AI Analysis

Summary

Physicians Joshua Richter and Marco Davila discussed whether patient selection may inflate reported CAR T-cell therapy outcomes in multiple myeloma, focusing on real-world treatment data.

Importance:3/10

Sentiment:

0.00

CAR T-cell therapymultiple myelomapatient selectionreal-world outcomes

Related Companies

$WHEN

Read the original article

Published by Cancer Network on August 9, 2026 4:00 PM

Read Original